A case of severe neuropathy associated with hypertriglyceridemia

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 1020-1022

  Hou, Runhua ^a   Goldberg, Anne Carol ^a   Tobin, Garry Stuart ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATININE; CYANOCOBALAMIN; GLUCOSE; HEMOGLOBIN; REAGINIC ANTIBODY; THYROTROPIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CREATININE BLOOD LEVEL; DIET RESTRICTION; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; LABORATORY TEST; NERVE CONDUCTION; PANCREATITIS; PERIPHERAL NEUROPATHY; SYMPTOM; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; MIDDLE AGED; PATHOLOGY;

FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 65849497951     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.1020     Document Type: Article

References (10)

1. Fessel WJ. Fat disorders and peripheral neuropathy. Brain. 1971;94:531-540
2. David WS, Mahdavi Z, Nance M, Khan M. Hyperlipidemia and neuropathy. Electromyogr Clin Neurophysiol. 1999;39: 227-230.
3. Sandbank U, Bubis JJ. Hyperlipaemic neuropathy, experimental study. Brain. 1973;96:355-358.
4. McManis PG, Windebank AJ, Kiziltan M. Neuropathy associated with hyperlipidemia. Neurology. 1994;44: 2185-2186.
5. Kassem HS, Azar ST, Zantout MS, Sawaya RA. Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients. Neuro Endocrinol Lett. 2005;26:775-779.
6. Chait A, Robertson HT, Brunzell JD. Chylomicronemia syndrome in diabetes mellitus. Diabetes Care. 1981;4: 343-348.
7. Harcos P, Márkus A, Péter A, Pucsok J. Intermittent cerebral symptoms in type V hyperlipoproteinemia. Eur Neurol. 1976;14:241-249.
8. Cullen CF, Swank RL. Intravascular aggregation and adhesiveness of the blood elements associated with alimentary lipemia and injections of large molecular substances; effect on blood-brain barrier. Circulation. 1954;9:335-346.
9. Meyer JS, Waltz AG. Effects of changes in composition of plasma in pial blood flow. I. Lipids and lipid fractions. Neurology. 1959;9:728-740.
10. Davis TM, Yeap B, Bruce DG, et al. Lipid-lowering therapy protects against peripheral sensory neuropathy in type 2 diabetes. Presented at: American Diabetes Association 67th Scientific Sessions; June 22-26, 2007; Chicago, IL. Abstract 0004-OR.